THE DAILY BRIEFING

A clearer view of today.

The stories that matter. The context you need.

INDEPENDENT PERSPECTIVEFree to read.
Every day.

Business

Your briefing

3 min read

AI-assisted briefingHow we put it together ↗
Goldman pushes back forecast for Fed rate cuts as inflation proves sticky

Goldman Sachs now expects the Federal Reserve to begin easing later than previously anticipated, citing slower progress on inflation. A longer “higher for longer” path could keep Treasury yields elevated, pressure rate‑sensitive sectors, and temper hopes for an imminent rebound in dealmaking and housing.

Source: SeekingAlpha All


Earnings season: 88% of S&P 500 reporters beat EPS estimates; breadth of growth strengthens

With most S&P 500 components now filed, 88% topped consensus EPS and 82% posted year‑over‑year earnings growth. The beat rate underscores resilient profits despite higher rates, with standouts in technology, energy, and utilities helping propel broader indexes.

Source: SeekingAlpha All


Micron logs best weekly gain since 2008 as AI memory demand ignites debate

Micron shares surged for their strongest week in nearly two decades, fueled by optimism that AI server demand will tighten memory supply and lift pricing. The move has re‑energized bulls on the semiconductor cycle while drawing bears’ scrutiny on sustainability and valuation after a sharp run‑up.

Source: SeekingAlpha All


Honeywell’s Quantinuum files for a U.S. IPO, bringing quantum computing to public markets

Quantinuum, majority owned by Honeywell, has confidentially prepared for a U.S. listing by filing an S‑1, aiming to tap public capital for next‑gen quantum hardware and software. A successful debut would be a fresh barometer for investor appetite in advanced computing amid a crowded AI capital cycle.

Source: SeekingAlpha All


Google’s Isomorphic Labs said to target over $2B in new funding

Alphabet’s Isomorphic Labs is reportedly pursuing a raise exceeding $2 billion to accelerate AI‑driven drug discovery. The prospective round would rank among the year’s largest life‑sciences financings and underscores the deepening convergence of big tech and biopharma R&D.

Source: SeekingAlpha All


U.S. shuns China‑linked solar factories amid Trump crackdown – Reuters

China‑affiliated solar plants in the U.S. are reportedly being frozen out of federal and private‑sector orders as the administration tightens scrutiny over supply chains. The shift threatens near‑term project timelines and capex plans, while potentially benefiting domestic and non‑China suppliers across the solar stack.

Source: SeekingAlpha All


Lumentum to join the Nasdaq‑100, replacing CoStar

Lumentum will be added to the Nasdaq‑100 index, displacing CoStar, triggering passive rebalancing flows across index‑tracking funds. Membership often improves liquidity and broadens the shareholder base, though inclusion effects can be quickly priced in by active managers.

Source: SeekingAlpha All


You May Also Be Interested In…
Business — May 10, 2026 | Briefing24